Quantcast
Last updated on April 18, 2014 at 12:47 EDT

Latest Gynecologic oncology Stories

2011-09-13 10:52:00

OSCEOLA, Indiana, Sept. 13, 2011 /PRNewswire/ -- Tatum Ink - The most common gynecologic cancer is uterine cancer, also called endometrial cancer. "This year, 45,000 women will learn they have it; 8,000 will have it listed on their death certificates," says freelance journalist Rita Tatum, author of Sass cancer Back: Living with Spirit (Xlibris: 2011). "Many books offer hope for cervical and ovarian cancer warriors," says Tatum, who was diagnosed with stage 4 uterine cancer in 2006....

2011-09-08 09:00:00

Research Report to educate national policymakers as they prioritize research funding initiatives in women's health during a time of Federal funding constraints CHICAGO, Sept. 8, 2011 /PRNewswire-USNewswire/ -- In conjunction with September's designation as Gynecologic Cancer Awareness month, the Society of Gynecologic Oncology (SGO) has released a comprehensive research report entitled, "Pathways to Progress in Women's Cancer: A Research Agenda Proposed by the Society of Gynecologic...

2011-09-06 10:53:00

Journalist Joan Lunden to moderate discussion about cervical cancer screening and global women's health policies ANN ARBOR, Mich., Sept. 6, 2011 /PRNewswire-USNewswire/ -- In honor of national Women's Health and Fitness Day, U-M Von Voigtlander Women's Hospital, which moves into a state-of-the-art facility in November, will host a breakfast and panel discussion at 8:30 a.m., Wed., Sept. 28, 2011 at the North Campus Research Complex, 2800 Plymouth Rd., Ann Arbor. Moderated by journalist,...

2011-09-06 08:30:00

MALVERN, Pa., Sept. 6, 2011 /PRNewswire/ -- Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA(TM) (HE4 EIA + ARCHITECT CA 125 II(TM))* to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery....

2011-09-02 07:10:00

WYNNEWOOD, Pa., Sept. 2, 2011 /PRNewswire/ -- As a leading cause of death among women, ovarian cancer is known as a "silent killer." Rarely detected early, when it is more easily treated, ovarian cancer strikes over 20,000 women each year. It is estimated that over 15,000 women in America die each year from the disease. In the Philadelphia area, the Lorraine J. D'Emilio Foundation was started in 2011 in memory and honor of Lorraine J. D'Emilio. The foundation focuses on helping and...

2011-08-30 12:17:00

OSCEOLA, Ind., Aug. 30, 2011 /PRNewswire/ -- Tatum Ink - Freelance journalist Rita Tatum wants to lowercase the "Big C" in advanced uterine cancer diagnoses. "Surviving cancer's okay, but living's more fun," insists the author of Sass cancer Back: Living with Spirit (Xlibris: 2011). In 2006, Tatum was diagnosed with stage IV uterine cancer. "Early on, I survived like a deer frozen in oncoming headlights," Tatum says. "But faith, friends' prayers and timely doses of humor soon had me...

2011-08-15 14:41:00

OSCEOLA, Ind., Aug. 15, 2011 /PRNewswire/ -- Tatum Ink -- One of every 41 U.S. women will be diagnosed with uterine cancer in her lifetime. More than half will be 50 to 69 years old. In 2006, freelance journalist Rita Tatum, author of Sass cancer Back: Living with Spirit (Xlibris: 2011), became one of them. Uterine cancer, also called endometrial cancer, starts in the uterus' inner lining. When caught in early stages, it's highly curable. Five-year survival drops to between 15 and 25...

2011-06-16 07:00:00

MIAMI, June 16, 2011 /PRNewswire/ -- Drs. Nicholas C. Lambrou and Troy A. Gatcliffe are pleased to announce the opening of GYN Oncology of Miami. Fellowship trained in gynecologic oncology, Drs. Lambrou and Gatcliffe are specialists in the surgical and medical care of women's reproductive cancers. The new practice provides comprehensive gynecology services to women in South Florida and the Caribbean region from two convenient office locations in the Medical Arts Buildings of South Miami...

2011-06-06 16:39:00

PITTSBURGH, June 6, 2011 /PRNewswire/ -- Dr. Bradley Monk of the Creighton University School of Medicine presented a new gynecologic cancer study at the 2011 American Society of Clinical Oncology (ASCO) Annual Symposium, June 5th in Chicago, Illinois. The study, titled, Acquired Drug Resistance in Gynecologic Cancer Detected by an In Vitro Assay, begins to answer the question of whether ChemoFx® Drug Response Marker test results taken in the primary setting can be...

2011-06-06 08:30:00

MALVERN, Pa., June 6, 2011 /PRNewswire/ -- A study recently published online in the journal Clinica Chimica Acta validated the use of the HE4 test and the ROMA (Risk of Ovarian Malignancy Algorithm) algorithm in distinguishing malignant from benign pelvic masses in the Italian population. The authors of this study concluded that HE4 should be added to clinical and imaging criteria for the discrimination of benign from malignant pelvic masses in women suspected of having epithelial...